[Recombinant human alfa2-interferon (reaferon) in ointment form in the treatment of various diseases of the skin and mucosa]. 1990

V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
Institute of Immunology, Ministry of Medical Industry of the USSR, Moscow Region.

Clinical trials of the gene engineered human alpha 2-interferon as ointment were performed. The ointment was used in the treatment of patients with relapsing herpes of various localization, relapsing aphthous stomatitis and pemphigus vulgaris. It was shown that the ointment was harmless and its therapeutic effect was favourable. The preparation is recommended for introduction into the practice of public health.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009092 Mucous Membrane An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa. Lamina Propria,Mucosa,Mucosal Tissue,Muscularis Mucosae,Mucous Membranes,Membrane, Mucous,Membranes, Mucous,Mucosae, Muscularis,Mucosal Tissues,Propria, Lamina,Tissue, Mucosal,Tissues, Mucosal
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
January 1992, Pediatriia,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
September 1969, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
January 1985, Trudy Instituta imeni Pastera,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
January 1989, Voprosy virusologii,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
January 1990, Terapevticheskii arkhiv,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
January 1974, Przeglad dermatologiczny,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
December 1973, Munchener medizinische Wochenschrift (1950),
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
July 1988, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
July 1989, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V V Parfenov, and V N Grebeniuk, and E I Abramova, and Iu V Voronin, and V V Bumialis, and T N Volodina, and L A Denisov
October 1963, Clinique (Paris, France),
Copied contents to your clipboard!